ArriVent BioPharma, Inc. - Common Stock (AVBP)

Historical Holders from Q1 2024 to Q3 2025

Symbol
AVBP on Nasdaq
CUSIP
04272N102
Type / Class
Equity / Common Stock
Shares outstanding
41M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
33.6M
Holdings value
$732M
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
96
Number of buys
49
Number of sells
-38
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ArriVent BioPharma, Inc. - Common Stock (AVBP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INFINITUM ASSET MANAGEMENT, LLC 9.9% $65.7M 3.42M INFINITUM ASSET MANAGEMENT, LLC May 1, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 9.9% $65.6M 3.41M Suvretta Capital Management, LLC Jun 30, 2025
ORBIMED ADVISORS LLC 7.5% $58.2M 3.03M ORBIMED ADVISORS LLC Aug 11, 2025
HBM Healthcare Investments (Cayman) Ltd. 5.4% $40.5M 2.2M HBM Healthcare Investments (Cayman) Ltd. Oct 8, 2025
BlackRock, Inc. 4.9% $36.4M 2.01M BlackRock, Inc. Sep 30, 2025

Institutional Holders of ArriVent BioPharma, Inc. - Common Stock (AVBP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 101K $1.86M -$46.2K $18.45 7
2025 Q2 33.6M $732M +$99.6M $21.77 96
2025 Q1 29.1M $539M +$6.16M $18.49 82
2024 Q4 28.5M $757M +$26.6M $26.64 80
2024 Q3 25.9M $612M +$70.4M $23.50 67
2024 Q2 21M $389M -$3.33M $18.55 52
2024 Q1 21.9M $389M +$388M $17.86 53